previous compound ID: 1391 next compound
InChIKey: MLKXDPUZXIRXEP-MFOYZWKCSA-N
SMILES: CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "E Matthes" "R Robert" "D Rotin" "GW Carlile" "J Liao" "J Goepp" "SD Macknight" "JW Hanrahan" "B Kus"

chemical graph of compound 1391





CID is 1548887
synonyms found at PubChem are:
sulindac, Clinoril, 38194-50-2, Arthrocine, Sulindac sulfoxide, Sulindaco, Sulindacum, Mobilin, Arthrobid, Klinoril, MK 231, Sulindacum [INN-Latin], Sulindaco [INN-Spanish], Aflodac, MK-231, Clinoril (TN), Sulreuma, C20H17FO3S, CCRIS 3305, CHEBI:9352, (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid, Sulindac [USAN:BAN:INN:JAN], MK231, cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid, (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid, cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid, EINECS 253-819-2, BRN 2951842, Algocetil, Artribid, Citireuma, Clisundac, Imbaral, Reumofil, Sulinol, CHEMBL15770, Sudac, Copal, 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-, NCGC00015970-02, Copals, Copal resin, Resin copal, CAS-38194-50-2, Gum copal, DSSTox_CID_3624, S 8139, {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid, 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid, 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid, DSSTox_RID_77117, DSSTox_GSID_23624, Copal rosin varnish, Chibret, Kenalin, Sulindal, Aclin, cis-Sulindac, Novo Sundac, Novo-Sundac, Nu Sulindac, Nu-Sulindac, Sulindac (Clinoril), Apo Sulin, Apo-Sulin, (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid, 2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid, SR-01000075237, Moblilin, (Z)-2-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic Acid, 2-(5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylene}inden-3-yl)acetic acid, 32004-68-5, EINECS 250-893-8, EINECS 256-402-3, Sulindac [USAN:USP:INN:BAN:JAN], Tocris-1707, Merck Brand of Sulindac, AC1LU7GY, Apotex Brand of Sulindac, Chemia Brand of Sulindac, Clinoril;Aflodac;Sulreuma, KendrickBrand of Sulindac, Prestwick3_000073, Spectrum5_001024, Lopac-S-8139, D0Z5IU, Sulindac, >=98.0%, Novopharm Brand of Sulindac, Nu Pharm Brand of Sulindac, Nu-Pharm Brand of Sulindac, SCHEMBL4202, SCHEMBL4203, Sulindac (JAN/USP/INN), Alphapharm Brand of Sulindac, Lopac0_001070, BSPBio_000285, BSPBio_002890, MLS001056554, SPECTRUM1500556, Sulindac (JP17/USP/INN), BPBio1_000315, GTPL5425, DTXSID4023624, CHEBI:93811, HMS501O03, (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid, {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid, {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid, 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid, cMAP_000021, MLKXDPUZXIRXEP-MFOYZWKCSA-N, MolPort-003-666-287, HMS1921C11, HMS2092K15, HMS2095O07, HMS2231N24, HMS3259K06, HMS3263E22, HMS3649P19, HMS3712O07, Pharmakon1600-01500556, (E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid, [(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid, HY-B0008, Tox21_110270, Tox21_301418, Tox21_501070, BDBM50012899, BDBM50103504, CCG-39264, NSC757344, s2007, SBB058181, Cahill May Roberts Brand of Sulindac, AKOS015895412, cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid, Tox21_110270_1, CS-0569, DB00605, KS-5153, LP01070, Merck Sharp & Dohme Brand of Sulindac, NC00540, NSC-757344, (Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid, 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-, IDI1_000601, NCGC00015970-01, NCGC00015970-03, NCGC00015970-04, NCGC00015970-05, NCGC00015970-06, NCGC00015970-07, NCGC00015970-08, NCGC00015970-11, NCGC00025268-01, NCGC00025268-02, NCGC00025268-03, NCGC00094349-01, NCGC00094349-02, NCGC00255143-01, NCGC00261755-01, 49627-22-7, BP-30208, CPD000326718, LS-81610, SAM002554933, SMR000326718, SBI-0051040.P004, Sulindac, meets USP testing specifications, AB2000418, RT-000169, AB00513800, EU-0101070, ST24026687, ST51015123, U0099, 9222-EP2275420A1, 9222-EP2277565A2, 9222-EP2277566A2, 9222-EP2277567A1, 9222-EP2277568A2, 9222-EP2277569A2, 9222-EP2277570A2, 9222-EP2280008A2, 9222-EP2281815A1, 9222-EP2284166A1, 9222-EP2292280A1, 9222-EP2295055A2, 9222-EP2295409A1, 9222-EP2298764A1, 9222-EP2298765A1, 9222-EP2301933A1, 9222-EP2305640A2, 9222-EP2305652A2, 9222-EP2308872A1, 9222-EP2311453A1, 9222-EP2311827A1, 9222-EP2314585A1, 9222-EP2314590A1, 9222-EP2316829A1, C01531, D00120, W-5115, AB00052105-07, AB00052105_08, AB00052105_09, J-008554, J-012337, SR-01000075237-2, SR-01000075237-3, SR-01000075237-5, SR-01000075237-7, BRD-A13946108-001-04-9, BRD-A13946108-001-08-0, SR-01000075237-13, Sulindac, European Pharmacopoeia (EP) Reference Standard, Sulindac, United States Pharmacopeia (USP) Reference Standard, (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)-benzylidene)-1H-inden-3-yl)acetic acid, (Z)-5-Fluoro-2-methyl-1-[(p-methylsulfinyl)benzylidene]-1H-indene-3-acetic Acid, (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)-phenyl]methylene]-1H-indene-3-acetic acid, {(1z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-indene-3-yl}acetic acid, 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid, Sulindac|(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid